AAIC 2025 Abstract
Uncovering regional atrophy not explained by tau deposition using Additional Pathology Inference (AddiPath)
By Lawrence Peter Binding, Mihaela Croitor, Christopher S Parker, Show 3 more authorsAlexandra L Young
Study in peopleBiomarkers
Abstract
Background: Mixed pathology is prevalent in Alzheimer’s disease (AD) but difficult to detect in vivo as biomarkers for several additional pathologies are in their infancy. Cortical thickness (CT) atrophy reflects both tau deposition and additional pathologies (e.g., TDP‐43).
